Global Glaucoma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.

According to APO Research, The global Glaucoma Treatment market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Glaucoma Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Glaucoma Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Glaucoma Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Glaucoma Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Glaucoma Treatment include Novartis, Allergan, Pfizer, Akorn, Teva, Bausch & Lomb, Otsuka Pharmaceutical, Santen and Lunan Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Glaucoma Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Glaucoma Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Glaucoma Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glaucoma Treatment revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Glaucoma Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Glaucoma Treatment revenue, projected growth trends, production technology, application and end-user industry.


Glaucoma Treatment Segment by Company

Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma

Glaucoma Treatment Segment by Product
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Others

Glaucoma Treatment Segment by Application

Clinic
Pharmacy
Other

Glaucoma Treatment Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glaucoma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glaucoma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glaucoma Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Glaucoma Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glaucoma Treatment industry.
Chapter 3: Detailed analysis of Glaucoma Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glaucoma Treatmentrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Glaucoma Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prostaglandin Analogs (PGAs)
1.2.3 Beta Blocker
1.2.4 Alpha Agonist
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Global Glaucoma Treatment Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Market Growth Prospects
1.5 Global Glaucoma Treatment Growth Trends by Region
1.5.1 Global Glaucoma Treatment Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Glaucoma Treatment Market Size by Region (2020-2025)
1.5.3 Glaucoma Treatment Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Glaucoma Treatment Market Dynamics
2.1 Glaucoma Treatment Industry Trends
2.2 Glaucoma Treatment Industry Drivers
2.3 Glaucoma Treatment Industry Opportunities and Challenges
2.4 Glaucoma Treatment Industry Restraints
3 Competitive Landscape by Company
3.1 Global Glaucoma Treatment Revenue by Company (2020-2025)
3.2 Global Glaucoma Treatment Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Glaucoma Treatment Key Company Head office and Area Served
3.4 Global Glaucoma Treatment Company, Product Type & Application
3.5 Global Glaucoma Treatment Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Glaucoma Treatment Market CR5 and HHI
3.6.2 Global Top 5 and 10 Glaucoma Treatment Players Market Share by Revenue in 2024
3.6.3 2024 Glaucoma Treatment Tier 1, Tier 2, and Tier 3
4 Glaucoma Treatment Market by Type
4.1 Global Glaucoma Treatment Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Glaucoma Treatment Market Size by Type (2020-2031)
4.3 Global Glaucoma Treatment Market Size Share by Type (2020-2031)
5 Glaucoma Treatment Market by Application
5.1 Global Glaucoma Treatment Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Glaucoma Treatment Market Size by Application (2020-2031)
5.3 Global Glaucoma Treatment Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Novartis
6.1.1 Novartis Comapny Information
6.1.2 Novartis Business Overview
6.1.3 Novartis Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Novartis Glaucoma Treatment Product Portfolio
6.1.5 Novartis Recent Developments
6.2 Allergan
6.2.1 Allergan Comapny Information
6.2.2 Allergan Business Overview
6.2.3 Allergan Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 Allergan Glaucoma Treatment Product Portfolio
6.2.5 Allergan Recent Developments
6.3 Pfizer
6.3.1 Pfizer Comapny Information
6.3.2 Pfizer Business Overview
6.3.3 Pfizer Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Pfizer Glaucoma Treatment Product Portfolio
6.3.5 Pfizer Recent Developments
6.4 Akorn
6.4.1 Akorn Comapny Information
6.4.2 Akorn Business Overview
6.4.3 Akorn Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Akorn Glaucoma Treatment Product Portfolio
6.4.5 Akorn Recent Developments
6.5 Teva
6.5.1 Teva Comapny Information
6.5.2 Teva Business Overview
6.5.3 Teva Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Teva Glaucoma Treatment Product Portfolio
6.5.5 Teva Recent Developments
6.6 Bausch & Lomb
6.6.1 Bausch & Lomb Comapny Information
6.6.2 Bausch & Lomb Business Overview
6.6.3 Bausch & Lomb Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Bausch & Lomb Glaucoma Treatment Product Portfolio
6.6.5 Bausch & Lomb Recent Developments
6.7 Otsuka Pharmaceutical
6.7.1 Otsuka Pharmaceutical Comapny Information
6.7.2 Otsuka Pharmaceutical Business Overview
6.7.3 Otsuka Pharmaceutical Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 Otsuka Pharmaceutical Glaucoma Treatment Product Portfolio
6.7.5 Otsuka Pharmaceutical Recent Developments
6.8 Santen
6.8.1 Santen Comapny Information
6.8.2 Santen Business Overview
6.8.3 Santen Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Santen Glaucoma Treatment Product Portfolio
6.8.5 Santen Recent Developments
6.9 Lunan Pharma
6.9.1 Lunan Pharma Comapny Information
6.9.2 Lunan Pharma Business Overview
6.9.3 Lunan Pharma Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 Lunan Pharma Glaucoma Treatment Product Portfolio
6.9.5 Lunan Pharma Recent Developments
6.10 Zizhu Pharma
6.10.1 Zizhu Pharma Comapny Information
6.10.2 Zizhu Pharma Business Overview
6.10.3 Zizhu Pharma Glaucoma Treatment Revenue and Gross Margin (US$ Million) & (2020-2025)
6.10.4 Zizhu Pharma Glaucoma Treatment Product Portfolio
6.10.5 Zizhu Pharma Recent Developments
7 North America
7.1 North America Glaucoma Treatment Market Size (2020-2031)
7.2 North America Glaucoma Treatment Market Size by Type
7.2.1 North America Glaucoma Treatment Market Size by Type (2020-2025)
7.2.2 North America Glaucoma Treatment Market Size by Type (2026-2031)
7.2.3 North America Glaucoma Treatment Market Share by Type (2020-2031)
7.3 North America Glaucoma Treatment Market Size by Application
7.3.1 North America Glaucoma Treatment Market Size by Application (2020-2025)
7.3.2 North America Glaucoma Treatment Market Size by Application (2026-2031)
7.3.3 North America Glaucoma Treatment Market Share by Application (2020-2031)
7.4 North America Glaucoma Treatment Market Size by Country
7.4.1 North America Glaucoma Treatment Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Glaucoma Treatment Market Size by Country (2020-2025)
7.4.3 North America Glaucoma Treatment Market Size by Country (2026-2031)
7.4.4 North America Glaucoma Treatment Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Glaucoma Treatment Market Size (2020-2031)
8.2 Europe Glaucoma Treatment Market Size by Type
8.2.1 Europe Glaucoma Treatment Market Size by Type (2020-2025)
8.2.2 Europe Glaucoma Treatment Market Size by Type (2026-2031)
8.2.3 Europe Glaucoma Treatment Market Share by Type (2020-2031)
8.3 Europe Glaucoma Treatment Market Size by Application
8.3.1 Europe Glaucoma Treatment Market Size by Application (2020-2025)
8.3.2 Europe Glaucoma Treatment Market Size by Application (2026-2031)
8.3.3 Europe Glaucoma Treatment Market Share by Application (2020-2031)
8.4 Europe Glaucoma Treatment Market Size by Country
8.4.1 Europe Glaucoma Treatment Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Glaucoma Treatment Market Size by Country (2020-2025)
8.4.3 Europe Glaucoma Treatment Market Size by Country (2026-2031)
8.4.4 Europe Glaucoma Treatment Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Glaucoma Treatment Market Size (2020-2031)
9.2 China Glaucoma Treatment Market Size by Type
9.2.1 China Glaucoma Treatment Market Size by Type (2020-2025)
9.2.2 China Glaucoma Treatment Market Size by Type (2026-2031)
9.2.3 China Glaucoma Treatment Market Share by Type (2020-2031)
9.3 China Glaucoma Treatment Market Size by Application
9.3.1 China Glaucoma Treatment Market Size by Application (2020-2025)
9.3.2 China Glaucoma Treatment Market Size by Application (2026-2031)
9.3.3 China Glaucoma Treatment Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Glaucoma Treatment Market Size (2020-2031)
10.2 Asia Glaucoma Treatment Market Size by Type
10.2.1 Asia Glaucoma Treatment Market Size by Type (2020-2025)
10.2.2 Asia Glaucoma Treatment Market Size by Type (2026-2031)
10.2.3 Asia Glaucoma Treatment Market Share by Type (2020-2031)
10.3 Asia Glaucoma Treatment Market Size by Application
10.3.1 Asia Glaucoma Treatment Market Size by Application (2020-2025)
10.3.2 Asia Glaucoma Treatment Market Size by Application (2026-2031)
10.3.3 Asia Glaucoma Treatment Market Share by Application (2020-2031)
10.4 Asia Glaucoma Treatment Market Size by Country
10.4.1 Asia Glaucoma Treatment Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Glaucoma Treatment Market Size by Country (2020-2025)
10.4.3 Asia Glaucoma Treatment Market Size by Country (2026-2031)
10.4.4 Asia Glaucoma Treatment Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Glaucoma Treatment Market Size (2020-2031)
11.2 South America, Middle East & Africa Glaucoma Treatment Market Size by Type
11.2.1 South America, Middle East & Africa Glaucoma Treatment Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Glaucoma Treatment Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Glaucoma Treatment Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Glaucoma Treatment Market Size by Application
11.3.1 South America, Middle East & Africa Glaucoma Treatment Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Glaucoma Treatment Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Glaucoma Treatment Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Glaucoma Treatment Market Size by Country
11.4.1 South America, Middle East & Africa Glaucoma Treatment Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Glaucoma Treatment Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Glaucoma Treatment Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Glaucoma Treatment Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings